AP NEWS

Report: Exploring Fundamental Drivers Behind J.B. Hunt Transport Services, Kura Oncology, National Beverage, Benefitfocus, PTC Therapeutics, and Walgreens Boots Alliance — New Horizons, Emerging Trends, and Upcoming Developments

November 30, 2018

NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT), Kura Oncology, Inc. (NASDAQ:KURA), National Beverage Corp. (NASDAQ:FIZZ), Benefitfocus, Inc. (NASDAQ:BNFT), PTC Therapeutics, Inc. (NASDAQ:PTCT), and Walgreens Boots Alliance, Inc. (NASDAQ:WBA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

JBHT DOWNLOAD: http://Fundamental-Markets.com/register/?so=JBHT KURA DOWNLOAD: http://Fundamental-Markets.com/register/?so=KURA FIZZ DOWNLOAD: http://Fundamental-Markets.com/register/?so=FIZZ BNFT DOWNLOAD: http://Fundamental-Markets.com/register/?so=BNFT PTCT DOWNLOAD: http://Fundamental-Markets.com/register/?so=PTCT WBA DOWNLOAD: http://Fundamental-Markets.com/register/?so=WBA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT), Kura Oncology, Inc. (NASDAQ:KURA), National Beverage Corp. (NASDAQ:FIZZ), Benefitfocus, Inc. (NASDAQ:BNFT), PTC Therapeutics, Inc. (NASDAQ:PTCT), and Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 28th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

J.B. HUNT TRANSPORT SERVICES, INC. (JBHT) REPORT OVERVIEW

J.B. Hunt Transport Services’ Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, J.B. Hunt Transport Services reported revenue of $2,209.76MM vs $1,843.33MM (up 19.88%) and analysts estimated basic earnings per share $1.20 vs $0.92 (up 30.43%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, J.B. Hunt Transport Services reported revenue of $7,189.57MM vs $6,555.46MM (up 9.67%) and analysts estimated basic earnings per share $6.24 vs $3.84 (up 62.50%). Analysts expect earnings to be released on January 17th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.04. The estimated EPS forecast for the next fiscal year is $6.38 and is expected to report on January 17th, 2019.

To read the full J.B. Hunt Transport Services, Inc. (JBHT) report, download it here: http://Fundamental-Markets.com/register/?so=JBHT

-----------------------------------------

KURA ONCOLOGY, INC. (KURA) REPORT OVERVIEW

Kura Oncology’s Recent Financial Performance

Analysts expect earnings to be released on March 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.37. The estimated EPS forecast for the next fiscal year is -$2.01 and is expected to report on March 11th, 2019.

To read the full Kura Oncology, Inc. (KURA) report, download it here: http://Fundamental-Markets.com/register/?so=KURA

-----------------------------------------

NATIONAL BEVERAGE CORP. (FIZZ) REPORT OVERVIEW

National Beverage’s Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, National Beverage reported revenue of $292.59MM vs $259.83MM (up 12.61%) and analysts estimated basic earnings per share $1.05 vs $0.82 (up 28.05%). For the twelve months ended April 30th, 2018 vs April 30th, 2017, National Beverage reported revenue of $975.73MM vs $826.92MM (up 18.00%) and analysts estimated basic earnings per share $3.21 vs $2.30 (up 39.57%). Analysts expect earnings to be released on December 6th, 2018. The report will be for the fiscal period ending October 31st, 2018. Reported EPS for the same quarter last year was $0.72. The estimated EPS forecast for the next fiscal year is $4.43 and is expected to report on June 26th, 2019.

To read the full National Beverage Corp. (FIZZ) report, download it here: http://Fundamental-Markets.com/register/?so=FIZZ

-----------------------------------------

BENEFITFOCUS, INC. (BNFT) REPORT OVERVIEW

Benefitfocus’ Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Benefitfocus reported revenue of $61.01MM vs $56.25MM (up 8.45%) and basic earnings per share -$0.36 vs -$0.45. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Benefitfocus reported revenue of $256.74MM vs $233.34MM (up 10.03%) and analysts estimated basic earnings per share -$0.83 vs -$1.35. Analysts expect earnings to be released on March 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.20. The estimated EPS forecast for the next fiscal year is -$0.70 and is expected to report on March 13th, 2019.

To read the full Benefitfocus, Inc. (BNFT) report, download it here: http://Fundamental-Markets.com/register/?so=BNFT

-----------------------------------------

PTC THERAPEUTICS, INC. (PTCT) REPORT OVERVIEW

PTC Therapeutics’ Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, PTC Therapeutics reported revenue of $53.59MM vs $41.85MM (up 28.05%) and analysts estimated basic earnings per share -$1.06 vs -$0.82. For the twelve months ended December 31st, 2017 vs December 31st, 2016, PTC Therapeutics reported revenue of $194.39MM vs $82.71MM (up 135.04%) and analysts estimated basic earnings per share -$2.02 vs -$4.17. Analysts expect earnings to be released on March 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.03. The estimated EPS forecast for the next fiscal year is -$2.49 and is expected to report on March 5th, 2019.

To read the full PTC Therapeutics, Inc. (PTCT) report, download it here: http://Fundamental-Markets.com/register/?so=PTCT

-----------------------------------------

WALGREENS BOOTS ALLIANCE, INC. (WBA) REPORT OVERVIEW

Walgreens Boots Alliance’s Recent Financial Performance

For the three months ended August 31st, 2018 vs August 31st, 2017, Walgreens Boots Alliance reported revenue of $33,442.00MM vs $30,149.00MM (up 10.92%) and analysts estimated basic earnings per share $1.54 vs $0.77 (up 100.00%). For the twelve months ended August 31st, 2018 vs August 31st, 2017, Walgreens Boots Alliance reported revenue of $131,537.00MM vs $118,214.00MM (up 11.27%) and analysts estimated basic earnings per share $5.07 vs $3.80 (up 33.42%). Analysts expect earnings to be released on January 3rd, 2019. The report will be for the fiscal period ending November 30th, 2018. The reported EPS for the same quarter last year was $1.28. The estimated EPS forecast for the next fiscal year is $7.04 and is expected to report on October 10th, 2019.

To read the full Walgreens Boots Alliance, Inc. (WBA) report, download it here: http://Fundamental-Markets.com/register/?so=WBA

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

AP RADIO
Update hourly